1. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor. Issue 1 (December 2015) Authors: Nishimura, Toshio; Nakamura, Kazuto; Yamashita, Soichi; Ikeda, Sadatomo; Kigure, Keiko; Minegishi, Takashi Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients. Issue 4 (1st May 2018) Authors: Nakao, Kohshiro; Hirakawa, Takashi; Suwa, Hiroto; Kogure, Kayoko; Ikeda, Sadatomo; Yamashita, Soichi; Minegishi, Takashi; Kishi, Hiroshi Journal: International journal of gynecological cancer Issue: Volume 28:Issue 4(2018) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients. Issue 4 (May 2018) Authors: Nakao, Kohshiro; Hirakawa, Takashi; Suwa, Hiroto; Kogure, Kayoko; Ikeda, Sadatomo; Yamashita, Soichi; Minegishi, Takashi; Kishi, Hiroshi Journal: International journal of gynecological cancer Issue: Volume 28:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗